Lynnea Olivarez


Director, Mentorship

VP, Corporate Communications at Encoded Therapeutics



Lynnea Olivarez is a life sciences communicator with deep-seated experience supporting a variety of biopharmaceutical functions and organizations. She is currently VP, Corporate Communications at Encoded Therapeutics, an up-and-coming gene therapy company based in the Bay Area. Before that, she was director, External Affairs and Communications at Intellia Therapeutics, a leading genome editing company in Cambridge, MA, and was recognized for her work there by PR News as an honoree of the Annual Top Women in PR Awards, Class of 2020. Prior to joining Intellia, she guided public relations strategy for life science companies as a senior director at Ten Bridge Communications and previously, as a member of MacDougall Biomedical Communications’ media practice. Earlier in her career, Lynnea led marketing and communications activities for the Massachusetts Life Sciences Center, the agency charged with implementing the state’s $1 billion life science initiative. Before her time in government, Lynnea managed global internal communications for Novartis Institutes for Biomedical Research’s informatics and technology team. She began her career at MA’s industry trade association, MassBio. Lynnea graduated magna cum laude from Northeastern University with a bachelor’s degree in journalism. Previously co-lead of the membership committee for the Boston chapter of the Public Relation Society of America (PRSA), she now serves on the board for the San Francisco Bay Area Chapter as director of mentorship.